{
  "ticker": "PYC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970878",
  "id": "02970878",
  "pages": 11,
  "price_sensitive": true,
  "date": "20250721",
  "time": "0842",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250721/pdf/06lz6y79ply9b4.pdf",
  "summary": "Here is the material information extracted from the ASX announcement, formatted concisely:\n\n- **Capital Raising**:  \n  - $146m raised in Q1 CY25 (previously announced on 17 April 2025).  \n  - Cash runway extended to >$200m (into CY27).  \n\n- **Operational Highlights (Q2 2025)**:  \n  - **Polycystic Kidney Disease (PKD)**:  \n    - First subject dosed in Phase 1a/1b trial; cohorts 1 & 2 completed in SAD study.  \n    - FDA alignment on single 12-month Phase 2 trial for approval.  \n  - **Retinitis Pigmentosa (RP11)**:  \n    - Phase 1/2 data showed improved vision; FDA alignment on registrational trial framework.  \n  - **Optic Atrophy (ADOA)**:  \n    - Cohort 2 dosing completed; escalation to final cohort approved.  \n  - **Neurodevelopmental Disorder (PMS)**:  \n    - Preclinical data supports progression to human trials (planned 2026).  \n\n- **Financials (Appendix 4C)**:  \n  - Cash balance (30 June 2025): **$153m** (excluding expected $20m R&D rebate in H2).  \n  - Net operating cash outflow: **$17.7m** (quarter), **$51.6m** (12 months).  \n  - Estimated funding runway: **8.7 quarters** based on current burn rate.  \n\n- **Upcoming Milestones (H2 2025)**:  \n  - PKD: Complete Phase 1a/1b dose escalation, initiate patient studies.  \n  - RP11: FDA meeting to finalize registrational trial design.  \n  - ADOA: Complete Phase 1 SAD, initiate Phase 1/2 MAD.  \n  - PMS: Advance toxicology studies for IND submission.  \n\n*Omitted: Director names, legal boilerplate, and non-material pipeline details.*",
  "usage": {
    "prompt_tokens": 6577,
    "completion_tokens": 424,
    "total_tokens": 7001,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-20T22:58:02.773900"
}